Gland Celsus Bio Cheicals Profile
Key Indicators
- Authorised Capital ₹ 2.32 Cr
as on 03-05-2024
- Paid Up Capital ₹ 1.25 Cr
as on 03-05-2024
- Company Age 33 Year, 7 Months
- Last Filing with ROC 31 Mar 2019
- Revenue -97.18%
(FY 2019)
- Profit -97.81%
(FY 2019)
- Ebitda 664.46%
(FY 2019)
- Net Worth 1.83%
(FY 2019)
- Total Assets -16.64%
(FY 2019)
About Gland Celsus Bio Cheicals
- CIN/LLPIN
U24110TG1991PTC012637
- Company No.
012637
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 1991
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gland Celsus Bio Cheicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kalidindi Lakshmi  | Director | 05-Dec-1995 | Current |
| Venkata Penmetsa | Director | 03-Dec-2013 | Current |
Penmetsa Ravindranath  | Director | 01-Nov-2013 | Current |
Financial Performance and Corporate Structure Insights of Gland Celsus Bio Cheicals.
Gland Celsus Bio Cheicals Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 97.18% decrease. The company also saw a substantial fall in profitability, with a 97.81% decrease in profit. The company's net worth moved up by a moderate rise of 1.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gland Celsus Bio Cheicals?
In 2019, Gland Celsus Bio Cheicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ilabs Info Technology Center (Gurgaon) Private LimitedActive 19 years 6 monthsKalidindi Lakshmi is a mutual person
Valar Capital Advisory LlpActive 6 years 10 monthsKalidindi Lakshmi and Penmetsa Ravindranath are mutual person
Ksk Energy Ventures LimitedActive 23 years 10 monthsKalidindi Lakshmi and Penmetsa Ravindranath are mutual person
Dhananjaya Properties LlpActive 9 years 11 monthsKalidindi Lakshmi and Penmetsa Ravindranath are mutual person
- Markanday Properties LlpActive 9 years 11 months
Kalidindi Lakshmi and Penmetsa Ravindranath are mutual person
- Sasikala Properties LlpActive 9 years 11 months
Kalidindi Lakshmi and Penmetsa Ravindranath are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gland Celsus Bio Cheicals?
Unlock and access historical data on people associated with Gland Celsus Bio Cheicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gland Celsus Bio Cheicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gland Celsus Bio Cheicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
